A phase III trial of capivasertib and fulvestrant versus placebo and fulvestrant in patients with HR+/HER2- breast cancer (CAPItello-291) Meeting Abstract
| Authors: | Turner, N.; Howell, S.; Jhaveri, K.; Gomez, H.; Toi, M.; Hu, X.; Loibl, S.; Rugo, H. S.; Ni, P.; De Bruin, E.; Orbegoso, C. M. A. A.; Schiavon, G.; Foxley, A.; Oliveira, M. |
| Abstract Title: | A phase III trial of capivasertib and fulvestrant versus placebo and fulvestrant in patients with HR+/HER2- breast cancer (CAPItello-291) |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S388 |
| End Page: | S389 |
| Language: | English |
| ACCESSION: | WOS:000573469100350 |
| DOI: | 10.1016/j.annonc.2020.08.452 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 350TiP -- Source: Wos |
